Ventyx Biosciences (VTYX) | Stock Overview & Key Data
Ventyx Biosciences Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $47.25 on February 27, 2023
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ventyx Biosciences
VTYX
|
1.00B Small-cap | 0.21% | 0.29% | 59.09% | 488.24% | 66.67% | 839.60% | -64.30% | -24.93% | -24.93% | -24.93% | -24.93% |
|
Vertex
VRTX
|
109.45B Large-cap | -2.03% | -0.35% | -9.68% | -7.51% | -5.26% | 1.24% | 34.08% | 113.19% | 376.31% | 717.28% | 1,190.86% |
|
Regeneron
REGN
|
80.98B Large-cap | -1.40% | -12.73% | -19.27% | -14.47% | -20.27% | 25.39% | -16.92% | 20.10% | 53.41% | 959.24% | 4,557.42% |
|
Stoke Therapeutics
STOK
|
2.07B Mid-cap | -6.33% | -13.81% | -12.79% | -4.84% | -4.66% | 224.00% | 153.99% | -17.13% | 13.26% | 13.26% | 13.26% |
|
Tyra Biosciences
TYRA
|
2.18B Mid-cap | -13.51% | -18.36% | -13.09% | 32.21% | 7.09% | 267.14% | 129.94% | 67.81% | 67.81% | 67.81% | 67.81% |
|
Ultragenyx
RARE
|
2.37B Mid-cap | -4.19% | -9.67% | 1.54% | -38.52% | -5.04% | -29.65% | -52.92% | -74.03% | -65.57% | -43.34% | -43.34% |
Ownership & Short Interest
Calculate Your Ventyx Biosciences Investment Returns
Long-Term Investment Performance Analysis
Ventyx Biosciences stock price in Oct 2021 was $18.65, A $1,000.00 lump sum investment in Ventyx Biosciences made 4 years ago would be worth approximately $750.67 today, representing a negative return of -24.93%. This translates to an annualized return (CAGR) of -6.34%.
4 Years 4 Months Investment Scenario (Oct 2021 - Mar 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is VTYX's 52-week high and low?
- In the last 52 weeks, Ventyx Biosciences reached a high of $25.00 (on January 6, 2026) and a low of $0.78 (on April 7, 2025).
- What is the market cap and P/E ratio for VTYX?
- Curious about Ventyx Biosciences's size and valuation? Its market capitalization stands at 1.00B. When it comes to valuation, the P/E ratio (trailing twelve months) is -7.11, and the forward P/E (looking ahead) is -8.94.
- Does VTYX pay dividends? If so, what's the yield?
- As for dividends, Ventyx Biosciences isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Ventyx Biosciences's main competitors or similar companies to consider before investing?
When looking at Ventyx Biosciences, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Vertex
VRTX109.45B Healthcare Biotechnology 1.24% 34.08% Regeneron
REGN80.98B Healthcare Biotechnology 25.39% -16.92% Stoke Therapeutics
STOK2.07B Healthcare Biotechnology 224.00% 153.99% Tyra Biosciences
TYRA2.18B Healthcare Biotechnology 267.14% 129.94% Ultragenyx
RARE2.37B Healthcare Biotechnology -29.65% -52.92% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Ventyx Biosciences Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Ventyx Biosciences's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -45.35%, the Debt to Equity ratio from the most recent quarter is 5.24, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for VTYX?
- Looking at Ventyx Biosciences's growth, its revenue over the trailing twelve months (TTM) was $0. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
- How much of VTYX stock is held by insiders and institutions?
- Wondering who owns Ventyx Biosciences stock? Company insiders (like executives and directors) hold about 4.22% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 84.50%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.